mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.049 |
0.1 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.1 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.1 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
0.051 |
0.1 |
mRNA |
CMK |
GDSC1000 |
pan-cancer |
AAC |
0.078 |
0.1 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.1 |
mRNA |
Pazopanib |
GDSC1000 |
pan-cancer |
AAC |
0.05 |
0.1 |